Allergic rhinitis
Conditions
Interventions
the control group:adopting referenced dose adjustment schedule
the experimental group:adopting new dose adjustment schedule
Sponsors
The First People's Hospital of Foshan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 5-60 years; 2. Patients with typical ar history and clinical symptoms of intermittent or persistent paroxysmal sneezing, clear water like snot, rhinopruritus and nasal obstruction; 3. The specific IgE of house dust mite and dust mite allergen in skin prick test was >= 0.70 Ku / L; 4. Patients with delayed injection in the routine subcutaneous immunotherapy of "Arog".
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women; 2. Patients with severe or uncontrolled asthma (FEV1 < 70% of predicted value) and irreversible respiratory obstructive diseases; 3. Patients with hypertension and coronary heart disease who are not suitable for adrenaline treatment; 4. Patients with severe immune diseases; 5. Patients with severe psychological disorders, or unable to understand the risks and limitations of treatment; 6. Patients with malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| severe local reaction;systemic reaction;satisfaction scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| symptom score;medication score;life quality score; | — |
Countries
China
Contacts
Public ContactQingqing Yu
The First People's Hospital of Foshan
Outcome results
None listed